Thirty out of the 41 analysts tracking the company have a 'buy' rating on the stock, seven suggest a 'hold' and four have a ...

Stay up-to-date with the Sun Pharma Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on ...

Welcome to the Sun Pharma Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most ...

Most brokerages retained ratings and target prices for Sun Pharmaceutical Industries after its second quarter earnings beat ...

After a US Court blocked the launch of Leqselvi, a drug used to treat severe alopecia areata, shares of Sun Pharma plunged ...

This decision delays Sun Pharma's planned US launch of the product, which could be deferred for several months if the company ...

Shares of several companies including M&M, Bharti Airtel, Nykaa, and Sun Pharma, among others, will be in the news today on ...

According to Citi, the delay in the launch of Sun Pharma's alopecia areata drug, Leqselvi, could impact its near-term ...

Sun Pharma's R&D expenses totaled ₹792.9 crore, or 6% of sales for the quarter, as the company advances its worldwide specialty pipeline. This includes the recent approval by the US FDA of ...

Shares of Sun Pharmaceuticals, the biggest pharmaceutical company of India fell 1.71 per cent at Rs 1870 per share on the BSE ...

What is the Sun Pharmaceuticals Industries Ltd share price today? The Sun Pharmaceuticals Industries Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹1869.75 today. What is the Market Cap ...